Protek Group Tops List of Pharmaceutical Industry in TOP-200 of Largest Private Companies in Russia

Protek Group took 32nd place in the rating of 200 largest private companies in Russia, published in Forbs magazine. At the end of 2020, the revenue of the Group exceeded 293 billion rubles, its staff amounted to about 19 thousand employees. Protek topped the list of representatives of the pharmaceutical industry - in addition to the Group, the rating includes Katren and Pulse (distribution segment), Pharmstandard and R-Pharm (production), Erkafarm (retail).

Compared to 2019, the position of Protek Group in the rating has increased by two points; it took 34th place with revenue of 265.6 billion rubles.

GK Protek justifiably entered the TOP-200 of the largest private companies and topped the list of representatives of the pharmaceutical business. At the end of 2020, the Group's revenue increased by 11% compared to 2019. The manufacturing segment showed the highest growth rate — 28%. The company, which has successfully developed according to the principle of a diversified business for many years and was represented in all regions of Russia, continues to form new market trends today. Today Protek is an ecosystem that has united pharmaceutical and medical directions and has taken as a basis a personalized approach to the end consumer, - said Vadim Muzyayev, President of Protek Group.
News list
сотекс Рафарма протеин протек транссервис
спарго протек-свм ригла протек фонд
PROTEK JSC uses cookies (files with data about previous visits to the website) for personalization of our services and their usability. PROTEK JSC takes personal data protection seriously. You may prevent cookies from being stored in your browser's settings.